GT Voice: HK boasts distinctive strengths to become drug innovation hub_蜘蛛资讯网
Guangdong Province's 15th Five-Year Plan (2026-30) explicitly states that the province will develop the biopharmaceutical industry aimed at improving the health and well-being of the people. This mean
Hong Kong is not only the first stop to access the international capital market but also a strategic pivot for connecting with international regulatory standards, conducting global multi-center clinic
